Eric Smith
Analyst
Cancer Fitzgerald
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eric Smith
Eric Smith is recorded as Analyst at Cancer Fitzgerald. Eric Smith has spoken on 1 earnings call across 1 company, most recently for Legend Biotech Corp on May 12, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cancer Fitzgerald
Analyst
Transcript header (unverified)
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.